Herb Profile
Botanical profile with evidence, safety, and practical fit.
Last reviewed: •13 human studies cited
A StrongUse extra caution — GI upset, rare thyroid stimulation Details
Monograph visual
Ashwagandha Withania Somnifera
The Hippie Scientist illustration
Best for
Not ideal for
Safety: Discuss with a clinician first if you have thyroid disease, are pregnant, or take sedatives; rare liver-injury reports exist.
On the evidence: Multiple randomized trials for stress and cortisol, though many are small and industry-funded.
Consider instead: L-theanine — for acute, in-the-moment calm
Why not higher
Why not lower
Practical takeaway: Reasonable to try for chronic stress over 6–8 weeks. It is a support, not a treatment for a diagnosed anxiety or mood disorder — involve a clinician for those.
Start here — new to this? Begin with Ashwagandha for anxiety & stress
Compare before choosing
Continue reading
Evidence Engine proof of concept
A claim-level view for one practical question: does the evidence justify considering ashwagandha for perceived stress?
Bottom line
Several short randomized placebo-controlled trials in adults with self-reported stress report improvements on perceived-stress or anxiety scales, often alongside cortisol changes.
The signal is not strong enough for hype: studies are small, short, often use different branded extracts, and at least one relevant trial in stressed, fatigued adults did not reduce perceived stress versus placebo.
This claim matters most to generally healthy adults comparing non-prescription options for everyday stress, especially when stress feels tense, sleep-adjacent, or rumination-heavy.
Decision snapshot
The evidence supports a cautious trial only for people whose safety context fits. It does not support treating ashwagandha as risk-free or as a replacement for care.
✓ Consider with caution
Best-supported action for a generally healthy adult after reviewing pregnancy, thyroid, liver, autoimmune, sedative, blood-pressure, blood-sugar, and medication concerns.
Consider
Too casual for this claim because the benefit signal is short-term and the safety profile has real caveats.
Experimental
The human evidence is stronger than purely experimental, but extract-specific uncertainty remains.
Avoid in context
Applies when pregnant or breastfeeding, with liver disease history, thyroid instability, hormone-sensitive prostate cancer, or relevant medication risk unless a clinician says otherwise.
Not enough evidence
Not the right overall label: multiple human trials exist, but they are not definitive.
Evidence breakdown
High
The core signal comes from randomized placebo-controlled trials in human adults reporting stress, not only from animal or mechanistic data.
Moderate-high
Most supportive studies measure perceived stress or anxiety directly, but preparations, doses, outcome scales, and stress definitions differ.
Moderate
Placebo control and blinding help, while small samples, short durations, branded extracts, and limited independent replication keep confidence below strong.
Moderate
Most trials point toward benefit, but not every relevant trial improves perceived stress; the disagreement changes the decision from simple “consider” to “consider with caution.”
Moderate
Potentially useful for subjective stress over 4–12 weeks, but it is not acute rescue, not a substitute for care, and not proven for long-term stress management.
Supporting evidence
| Year | Type | Population | Sample | Duration | Result | Relevance |
|---|---|---|---|---|---|---|
| 2012 | Randomized, double-blind, placebo-controlled trial | Adults with chronic self-reported stress | 64 | 60 days | High-concentration root extract improved perceived stress and related well-being measures versus placebo. | Directly supports the claim, but it is small and extract-specific. |
| 2019 | Randomized, double-blind, placebo-controlled three-arm trial | Stressed healthy adults with elevated perceived stress scores | 60 | 8 weeks | Ashwagandha groups reported greater stress reduction than placebo; pharmacologic stress markers also moved favorably. | Directly relevant to generally healthy adults, with dose comparison, but still small. |
| 2021 | Randomized, double-blind, placebo-controlled trial | Healthy stressed adults | 130 | 90 days | Sustained-release root extract improved validated stress and sleep measures and lowered cortisol versus placebo. | A larger short-term trial that supports the stress claim, though it uses one standardized extract. |
| 2022 | Randomized, placebo-controlled trial | Adults reporting perceived stress | 60 | 30 days | Root-and-leaf extract groups reported improvements in stress, anxiety, mood, and cravings; one dose lowered salivary cortisol. | Useful supportive signal, but the 30-day window and root/leaf extract limit generalization. |
Contradictory evidence
A 2023 trial in adults with high stress and fatigue found fatigue improvement but not a clear perceived-stress reduction versus placebo.
Population, baseline fatigue, extract chemistry, dose, study duration, and outcome sensitivity can all change whether perceived stress moves.
This keeps the label at Moderate and changes the practical state to “consider with caution,” not “strongly recommended.”
Safety before sourcing
What we still do not know
Source trail
Next decisions
Informational to commercial: understand what ashwagandha can and cannot support, then choose a standardized product with safety context.
| Use case | Evidence | Best fit | Typical range | Safety context |
|---|---|---|---|---|
| Stress and perceived tension | Moderate | Adults with chronic perceived stress | 300-600 mg/day standardized root extract | Review thyroid, pregnancy, autoimmune, liver, and sedative context. |
| Sleep quality | Moderate | Stress-linked sleep disruption | 300-600 mg/day, often evening or split dose | Can add to sedating products. |
| Anxiety symptoms | Preliminary to moderate | Stress-anxiety overlap, not acute panic | Trial windows usually 6-8 weeks | Not a replacement for anxiety care. |
| Testosterone/fertility markers | Preliminary | Stress-related male fertility or training contexts | Study-specific extracts; avoid broad hormone claims | Endocrine history changes the risk/benefit picture. |
KSM-66
Full-spectrum root extract
Often positioned for stress, sleep, performance, and general adaptogen use.
Sensoril
Root/leaf extract
Often more withanolide-dense; may feel more sedating for some users.
Gummies
Convenience only
Check dose, sugar alcohols, and whether extract standardization is disclosed.
GI upset, rare thyroid stimulation
60%
Moderate caution — review before use
Evidence-based safety
These pairings share a flagged risk mechanism. They are additive-effect cautions derived from contraindication data, not confirmed clinical interactions. Consult a clinician before combining.
Sedation / CNS depression
Browse the grouped cautions below. The list scrolls inside this card when long.
Most useful for practical interpretation when safety context also fits.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Neurotransmitter Modulation · Hormonal Signaling Context
Research maturity: More interpretable — Long Term Human Evidence May Be Limited.
Safety boundary: Safety note available — GI upset, rare thyroid stimulation
This profile cites 13 human studies.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
| Study | Type | Sample | Source |
|---|---|---|---|
(2024) | Meta-analysis | — | DOI → |
(2022) | Meta-analysis | — | DOI → |
Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis Cheah KL et al. (2021) | — | — | PubMed → |
Arumugam V et al. (2024) | — | — | PubMed → |
Lopresti AL et al. (2019) | — | — | PubMed → |
Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting With Supraventricular Tachycardia (2022) | — | — | DOI → |
Dose guidance
300 600 mg extract (KSM 66 or equivalent)
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Ashwagandha Withania Somnifera Works
Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.
Key constituents studied in Ashwagandha Withania Somnifera, with full pharmacology and safety profiles.
Goal guides
Condition guides
Compare side-by-side tradeoffs or verify active marker guidelines.
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Affiliate-ready sourcing
Affiliate recommendations for Ashwagandha Withania Somnifera. Review safety, dose, and product quality before buying.
Affiliate disclosure: we may earn a commission from qualifying links at no extra cost to you. How we stay independent.
When sourcing Ashwagandha Withania Somnifera, verify the label for:
Supplement stacking
Commonly paired with Ashwagandha Withania Somnifera. Review interactions and dosage before combining.
Affiliate disclosure: we may earn a commission from qualifying links at no extra cost to you. How we stay independent.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Free safety checklist
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Botanical profile context
Ashwagandha dosage ranges, effects, drug interactions, and harm-reduction safety guide for sleep. Strong Human Evidence research evidence. Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.
When reviewing Ashwagandha Withania Somnifera, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.
For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.